Hepatitis A vaccine responses in HIV-positive persons with haemophilia

Vaccine

Volumn 14, Issue 11, 1996, Pages 1039-1041

  Tilzey, Anthea J ^a   Palmer, Sara J ^a   Harrington, Chris ^a   O'Doherty, Michael J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Hepatitis A vaccine; HIV positive individuals with haemophilia; Subcutaneous route

Indexed keywords

HEPATITIS A VACCINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOPHILIA; HEPATITIS A; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION;

EID: 0030219524     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(96)00056-4     Document Type: Article

References (14)

1. 1 André, F.E., D'Hondt, E., Delem, A. and Safary, A. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings. Vaccine 1992, 10Suppl. 1, S160-S168
2. 2 Innis, B.L., Snitbhan, R., Kunasol, P. et al. Protection against hepatitis A by an inactivated vaccine. J. Am. Med. Assoc. 1994, 27117, 1328-1334
3. 3 Robertson, B.H., D'Hondt, E.H., Spelbring, J., Tian, H., Krawczynski, K. and Margolis, H.S. Effect of postexposure vaccination in a chimpanzee model of hepatitis A virus infection. J. Med. Virol. 1994, 43, 249-251
4. 4 Werzberger, A., Mensch, R.N., Kuter, B. et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. New Engl. J. Med. 1992, 3277, 453-457
5. 5 Manucci, P.M. for the Medical-Scientific Committee, Fondazione dell 'Emofilia. Outbreak of hepatitis A among Italian patients with haemophilia. Lancet 339, 1992, 819
6. 6 Gerritzen, A., Schneweis, K.E., Brackmann, H.-H. et al. Acute hepatitis A in haemophiliacs. Lancet 1992, 340, 1231-1232
7. 7 Robinson, S.M., Schwinn, H. and Smith, A. Clotting factors and hepatitis A. Lancet 1992, 340, 1465
8. 8 Shouval, D. and Gerlich, W.H. on behalf of the Working Group on Hepatitis A and Clotting Factors. Clotting factors and hepatitis A. Lancet 1992, 340, 1465
9. 9 Temperley, K.J., Cotter, K.P., Walsh, T.J., Power, J. and Hillary, I.B. Clotting factors and hepatitis A Lancet 1992, 340, 1466
10. 10 Peerlinck, K. and Vermylen, J. Acute hepatitis A in patients with haemophilia A. Lancet 1993, 341, 179
11. 11 Tilzey, A.J., Palmer, S.J., Barrow, S. et al. Clinical Trial with inactivated hepatitis A vaccine and recommendations for its use. Br. Med. J. 1992, 304, 1272-1276
12. 12 Delem, A. and Spreutels, M. Quantitative determination of anti-HAV antibodies induced by the HAVRIX vaccine-comparison of 5 test systems. In: Proceedings of the International Symposium on Enterically-Transmitted Hepatitis Viruses (Eds Buisson Y., Coursaget P. and Kane M.) (16-17 October 1995, Paris), in press
13. 13 Wiedermann, G., Ambrosch, F., André, F., D'Hondt, E., Delem, A. and Safary, A. Persistence of vaccine-induced antibody to hepatitis A virus. Vaccine 1992, 10Suppl. 1, 129S-131S
14. 14 Communicable Disease Surveillance Centre. AIDS and HIV-1 infection in the United Kingdom: monthly report. C.D.R. 1995, 5 No 29, 139-142